BioSyent Inc. (BIOYF)

BioSyent Income Statement

Financials in millions CAD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Revenue	31.59	27.93	28.62	22.33	21.42
Revenue Growth (YoY)	13.12%	-2.42%	28.15%	4.24%	-0.48%
Cost of Revenue	6.45	5.07	5.98	4.91	4.78
Gross Profit	25.14	22.86	22.64	17.42	16.65
Selling, General & Admin	17.53	15.28	13.66	11.52	11.17
Research & Development	0.08	0.22	0.28	0.24	0.09
Other Operating Expenses	0	0.45	0.46	0.54	0
Operating Expenses	17.61	15.95	14.39	12.3	11.26
Operating Income	7.53	6.98	8.18	5.03	5.39
Interest Income	1.13	0.53	0.14	0.26	0.45
Interest Expense	0.07	0.08	0.09	0.09	0.03
Other Expense / Income	0.06	-	-0.14	-0.04	-0.07
Pretax Income	8.53	7.43	8.38	5.24	5.87
Income Tax	2.07	1.97	2.1	1.44	1.5
Net Income	6.46	5.46	6.28	3.8	4.37
Net Income Growth	18.35%	-13.11%	65.51%	-13.14%	-23.42%
Shares Outstanding (Basic)	12	12	13	13	14
Shares Outstanding (Diluted)	12	13	13	13	14
Shares Change	-2.95%	-2.57%	-1.70%	-6.10%	-4.06%
EPS (Basic)	0.54	0.44	0.50	0.29	0.31
EPS (Diluted)	0.53	0.44	0.49	0.29	0.31
EPS Growth	20.45%	-10.20%	68.97%	-6.45%	-20.51%
Free Cash Flow	3.15	4.43	4.58	6.72	4.04
Free Cash Flow Per Share	0.26	0.35	0.36	0.51	0.29
Gross Margin	79.59%	81.85%	79.10%	78.02%	77.70%
Operating Margin	23.85%	25.00%	28.59%	22.52%	25.15%
Profit Margin	20.45%	19.55%	21.95%	16.99%	20.39%
Free Cash Flow Margin	9.98%	15.86%	16.01%	30.09%	18.84%
Effective Tax Rate	24.30%	26.54%	25.03%	27.53%	25.57%
EBITDA	7.99	7.88	8.97	5.9	6.13
EBITDA Margin	25.29%	28.23%	31.33%	26.42%	28.60%
Depreciation & Amortization	0.46	0.45	0.46	0.51	0.29
EBIT	7.53	7.43	8.51	5.39	5.84
EBIT Margin	23.85%	26.62%	29.74%	24.13%	27.24%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.